Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China-Reference-Cited by-同舟云学术

Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China

Published:2023-05 Issue: Volume:34 Page:100725
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Tang Xuewen^ORCID,Xiao Yanhui,Deng Xuan,Zhou Yang,Chen Haiping,Yan Rui,Zhu Yao,Wang Shengyi,Wang Hui,Zhu Xiujuan,Luo Linyun,Liu Yan,Yin Zhiying,Zhang Guoping,Chen Zhongbing,Jiang Jian,Yang Xiaoming,He Hanqing

Funder

Medical Science and Technology Project of Zhejiang Province

Zhejiang Provincial Health Commission

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference24 articles.

1. Mucosal immunity and the eradication of polio;Donlan;Science,2020

2. Addressing the challenges and opportunities of the polio endgame: lessons for the future;Manish;J Infect Dis,2017

3. Polio endgame: the global introduction of inactivated polio vaccine;Patel;Expert Rev Vaccines,2015

4. Polio endgame: the global switch from tOPV to bOPV;Garon;Expert Rev Vaccines,2016

5. Polio Eradication Strategy 2022–2026: Executive summary,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19

2. Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial;Vaccine;2024-03